Examining the Evidence : What Recent Cardiovascular Safety Trials Mean to the Treatment of High Risk Patients with Diabetes

Examining the Evidence : What Recent Cardiovascular Safety Trials Mean to the Treatment of High Risk Patients with Diabetes is organized by Pri-Med and would be held during Oct 08, 2015 - Oct 08, 2016. The target audience for this medical event are basically for physicians. This CME conference has been approved with a maximum of 1.50 AMA PRA Category 1 Credits.

Objectives :
• Explain the pathophysiologic links between type 2 diabetes and cardiovascular disease, with a focus on addressing specific modifiable cardiovascular risk factors.
• Discuss recent findings from cardiovascular safety studies and their clinical implications for patients with type 2 diabetes.
• Formulate individualized treatment plans for patients with type 2 diabetes so as to optimize glycemic control while mitigating cardiovascular risk.